Parnassus Endeavor Fund Buys AbbVie Inc, Biogen Inc, Regeneron Pharmaceuticals Inc, Sells Starbucks Corp, United Parcel Service Inc, CVS Health Corp

• New Purchases: ABBV, REGN,
• Added Positions: BIIB, PRGO, AAPL, MA, NVDA, COF, QCOM, IBM, GILD,
• Reduced Positions: SBUX, CELG, LRCX, AGN, AXP, IPGP, HBI, GOOGL, ADS,
• Sold Out: UPS, CVS, BMY,

For the details of Parnassus Endeavor Fund's stock buys and sells, go to https://www.gurufocus.com/guru/parnassus+endeavor+fund/current-portfolio/portfolio

1. Applied Materials Inc (AMAT) - 6,700,000 shares, 7.05% of the total portfolio.
2. Micron Technology Inc (MU) - 6,400,000 shares, 7.02% of the total portfolio.
3. Mattel Inc (MAT) - 19,500,000 shares, 6.73% of the total portfolio.
4. Cummins Inc (CMI) - 1,500,000 shares, 6.29% of the total portfolio.
5. Gilead Sciences Inc (GILD) - 3,100,000 shares, 5.35% of the total portfolio. Shares added by 3.33%

Parnassus Endeavor Fund initiated holding in AbbVie Inc. The purchase prices were between $77.14 and $92.19, with an estimated average price of $82.08. The stock is now traded at around $77.95. The impact to a portfolio due to this purchase was 3.64%. The holding were 1,700,000 shares as of .

Parnassus Endeavor Fund initiated holding in Regeneron Pharmaceuticals Inc. The purchase prices were between $372.08 and $439.57, with an estimated average price of $411.49. The stock is now traded at around $322.40. The impact to a portfolio due to this purchase was 1.74%. The holding were 160,000 shares as of .

Parnassus Endeavor Fund added to a holding in Biogen Inc by 80.00%. The purchase prices were between $216.71 and $338.96, with an estimated average price of $315.3. The stock is now traded at around $229.02. The impact to a portfolio due to this purchase was 1.76%. The holding were 630,000 shares as of .

Parnassus Endeavor Fund added to a holding in Perrigo Co PLC by 77.27%. The purchase prices were between $38.75 and $50.22, with an estimated average price of $46.69. The stock is now traded at around $48.94. The impact to a portfolio due to this purchase was 1.09%. The holding were 1,950,000 shares as of .

Parnassus Endeavor Fund added to a holding in Apple Inc by 42.86%. The purchase prices were between $142.19 and $195.09, with an estimated average price of $169.29. The stock is now traded at around $202.86. The impact to a portfolio due to this purchase was 0.61%. The holding were 400,000 shares as of .

Parnassus Endeavor Fund added to a holding in Mastercard Inc by 100.00%. The purchase prices were between $181.18 and $235.87, with an estimated average price of $214.63. The stock is now traded at around $245.06. The impact to a portfolio due to this purchase was 0.5%. The holding were 160,000 shares as of .

Parnassus Endeavor Fund added to a holding in Capital One Financial Corp by 36.67%. The purchase prices were between $75.59 and $84.97, with an estimated average price of $81.25. The stock is now traded at around $91.60. The impact to a portfolio due to this purchase was 0.48%. The holding were 820,000 shares as of .

Parnassus Endeavor Fund sold out a holding in United Parcel Service Inc. The sale prices were between $94.45 and $112.13, with an estimated average price of $105.93.

Parnassus Endeavor Fund sold out a holding in CVS Health Corp. The sale prices were between $52.36 and $69.88, with an estimated average price of $61.96.

Parnassus Endeavor Fund sold out a holding in Bristol-Myers Squibb Company. The sale prices were between $45.12 and $53.8, with an estimated average price of $49.88.

Parnassus Endeavor Fund reduced to a holding in Starbucks Corp by 76.67%. The sale prices were between $61.53 and $74.34, with an estimated average price of $68.63. The stock is now traded at around $77.96. The impact to a portfolio due to this sale was -4.05%. Parnassus Endeavor Fund still held 700,000 shares as of .

Parnassus Endeavor Fund reduced to a holding in Celgene Corp by 67.86%. The sale prices were between $64.09 and $94.34, with an estimated average price of $87.12. The stock is now traded at around $95.46. The impact to a portfolio due to this sale was -3.33%. Parnassus Endeavor Fund still held 900,000 shares as of .

Parnassus Endeavor Fund reduced to a holding in Lam Research Corp by 26.67%. The sale prices were between $131.63 and $183.8, with an estimated average price of $166.29. The stock is now traded at around $199.94. The impact to a portfolio due to this sale was -1.49%. Parnassus Endeavor Fund still held 1,100,000 shares as of .

Parnassus Endeavor Fund reduced to a holding in Allergan PLC by 63.64%. The sale prices were between $132.09 and $160.79, with an estimated average price of $144.95. The stock is now traded at around $141.36. The impact to a portfolio due to this sale was -1.28%. Parnassus Endeavor Fund still held 200,000 shares as of .

Parnassus Endeavor Fund reduced to a holding in American Express Co by 23.06%. The sale prices were between $93.43 and $113.55, with an estimated average price of $104.9. The stock is now traded at around $118.22. The impact to a portfolio due to this sale was -1.08%. Parnassus Endeavor Fund still held 1,385,000 shares as of .

Parnassus Endeavor Fund reduced to a holding in IPG Photonics Corp by 26.55%. The sale prices were between $108.6 and $161.18, with an estimated average price of $141.17. The stock is now traded at around $158.56. The impact to a portfolio due to this sale was -0.82%. Parnassus Endeavor Fund still held 734,458 shares as of .